PRECISE and Temus establish Joint Innovation Centre to advance precision health in Singapore

The JIC's primary purpose is to translate precision medicine research into practical applications by strengthening digital infrastructure, operating models, and safeguards for genomic data. This involves ensuring that the technology and processes can securely and responsibly manage the large datasets generated as Singapore's national program scales up.

Phase III of the NPM program, launched in November 2025, intends to sequence about 10 percent of Singapore’s local resident population. Professor Patrick Tan, Executive Director of PRECISE, stated that this phase is about ensuring the secure and responsible management of genomic data to support both research and care. The JIC provides a practical way to develop and maintain the necessary platforms without compromising security or scientific quality.

The collaboration builds on prior work between PRECISE and Temus since 2024, which included plans for a secure genomics data infrastructure capable of handling 13.6 petabytes, scaling to over 60 petabytes. This infrastructure aims to reduce data-processing timelines from weeks to days and generate genome-wide association results for 100,000 genomes, encompassing data pipelines, research platforms, and visualization solutions.